Researcher.Life Logo

Hepatobiliary and Pancreatic Diseases International : Impact Factor & More

eISSN: 2352-9377pISSN: 1499-3872

Key Metrics

CiteScore
5.2
Eigenfactor
0.001 - 0.005
Impact Factor
< 5
SJR
Q3Hepatology
SNIP
1.1
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Hepatobiliary and Pancreatic Diseases International

Hepatobiliary and Pancreatic Diseases International Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher ELSEVIER
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year2002
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Hepatobiliary and Pancreatic Diseases International ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Hepatobiliary and Pancreatic Diseases International

Liver xenotransplantation: Progress, mechanistic barriers and strategies for clinical translation.
  • 1 May 2026
  • Hepatobiliary & pancreatic diseases international : HBPD INT
Combined Bio-histological assessment as a tool to refine diagnosis and avoid overtreatment of early T-cell-mediated rejection after liver transplantation.
  • 30 Apr 2026
  • Hepatobiliary & pancreatic diseases international : HBPD INT
Modulating hepatic stellate cell senescence: A promising therapeutic strategy for liver fibrosis.
  • 27 Apr 2026
  • Hepatobiliary & pancreatic diseases international : HBPD INT
Proximal splenic artery ligation improves liver reperfusion, mitigates graft injury and decreases complications after liver transplantation.
  • 15 Apr 2026
  • Hepatobiliary & pancreatic diseases international : HBPD INT
A rare case of emphysematous liver abscess.
  • 15 Apr 2026
  • Hepatobiliary & pancreatic diseases international : HBPD INT
Is the 0.80% graft-to-recipient weight threshold still relevant in modern adult living donor liver transplantation?
  • 10 Apr 2026
  • Hepatobiliary & pancreatic diseases international : HBPD INT
Liver xenotransplantation: Progress, mechanistic barriers and strategies for clinical translation.
  • 1 May 2026
  • Hepatobiliary & pancreatic diseases international : HBPD INT
Combined Bio-histological assessment as a tool to refine diagnosis and avoid overtreatment of early T-cell-mediated rejection after liver transplantation.
  • 30 Apr 2026
  • Hepatobiliary & pancreatic diseases international : HBPD INT
Modulating hepatic stellate cell senescence: A promising therapeutic strategy for liver fibrosis.
  • 27 Apr 2026
  • Hepatobiliary & pancreatic diseases international : HBPD INT
Proximal splenic artery ligation improves liver reperfusion, mitigates graft injury and decreases complications after liver transplantation.
  • 15 Apr 2026
  • Hepatobiliary & pancreatic diseases international : HBPD INT
A rare case of emphysematous liver abscess.
  • 15 Apr 2026
  • Hepatobiliary & pancreatic diseases international : HBPD INT
Is the 0.80% graft-to-recipient weight threshold still relevant in modern adult living donor liver transplantation?
  • 10 Apr 2026
  • Hepatobiliary & pancreatic diseases international : HBPD INT

FAQs on Hepatobiliary and Pancreatic Diseases International